BioTelemetry, a Philips company

News

BioTelemetry, Inc. Reports First Quarter 2020 Financial Results

Announces Record Quarterly Revenue MALVERN, Pa., May 06, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended March 31, 2020. Quarter Highlights Recognized quarterly revenue of $113.0 million Reached 8.7% year-over-year quarterly revenue growth Achieved 31st consecutive quarter of year-over-year revenue growth Reported quarterly GAAP net income of $7.1 million, or 6.3% of revenue Realized quarterly adjusted EBITDA of $29.5 million, or 26.1% of revenue President and CEO Commentary Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: “I would like to first express my sincere gratitude to the entire BioTelemetry team and to our

Read More »

BioTelemetry, Inc. to Release First Quarter 2020 Earnings Results on May 6, 2020

MALVERN, Pa., April 29, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2020 earnings on Wednesday, May 6 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 6, 2020.  The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.  If you are unable to participate during the live webcast, an archive will be available on the website for two weeks. About BioTelemetry BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care.  We provide remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original

Read More »

BioTelemetry, Inc. to Move to Virtual-only Annual Stockholder Meeting for 2020

MALVERN, Pa., April 27, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that its 2020 Annual Meeting of Stockholders will be held virtually, moving away from an in-person event due to the evolving nature of the COVID-19 pandemic. Virtual meeting date:  Friday, May 8, 2020 Virtual meeting time:  8:30 a.m. EDT Virtual meeting link:  www.virtualshareholdermeeting.com/BEAT2020 Stockholders of record at the close of business March 10, 2020, are invited to vote their shares and register for the meeting at www.virtualshareholdermeeting.com/BEAT2020 using the instructions provided with their proxy materials that were issued beginning March 24, 2020.  Stockholders may submit questions in advance when

Read More »

BioTelemetry, Inc. Names Dr. Andrei Stoica Chief Technology Officer

MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Dr. Andrei Stoica has been named Chief Technology Officer of the company.  Dr. Stoica will lead the company’s global technology and product development operations, reporting to Joseph H. Capper, President and Chief Executive Officer. “We are delighted to welcome Andrei to our BioTelemetry team during this transformational time of growth and innovation,” said Joseph H. Capper, President and Chief Executive Officer of BioTelemetry.  “His extensive expertise in enterprise technology solutions, including cloud platforms, information security, and software and product development, will be instrumental as we continue to create

Read More »

BIOTELEMETRY, INC. EXPANDS MCOT™ SERVICE TO MONITOR LIFE-THREATENING QT PROLONGATION IN COVID-19 PATIENTS

Only remote cardiac monitoring company whose proprietary connected system has FDA-approved indication to measure, analyze and report QT interval MALVERN, Pa., March 25, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced the activation of an expanded service using its Mobile Cardiac Outpatient Telemetry (MCOT™) to monitor life-threatening QT prolongation in COVID-19 patients. As a reminder, MCOT is the most accurate and studied arrhythmia monitoring detection system in the market. It provides up to 30 days of near real time monitoring without patients needing to leave their homes. The Company is currently implementing this COVID-19 monitoring initiative in several major institutions and

Read More »

A COVID-19 Message from Joe Capper, President & CEO—Our Commitment to You

  Dear BioTelemetry Community, The health and safety of you and your patients is our highest priority.  As we work together during this challenging time, I want to assure you that we have never been more focused on making sure that you have the support you need from our company.   It is our privilege to work with you each day to make a difference in the lives of so many individuals and communities. This important work must continue while our experts work to address the COVID-19 outbreak worldwide.  As you navigate how to best provide your patients access to the critical care they need, we are here to help. Fortunately, patients can access our remote cardiac monitoring capabilities without ever leaving their homes, and we will

Read More »

BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results

Announces Record Quarterly and Full Year Results MALVERN, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter and year ended December 31, 2019. Quarter Highlights Recognized quarterly revenue of $112.0 million Reached 8.1% year-over-year quarterly revenue growth Achieved 30th consecutive quarter of year-over-year revenue growth Reported GAAP net income of $1.6 million, or 1.4% of revenue Realized quarterly adjusted EBITDA of $31.7 million, or 28.3% of revenue Received coverage from five new Blue Cross companies for MCT services President and CEO Commentary Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: “Our fourth

Read More »

BioTelemetry, Inc. to Release Fourth Quarter 2019 Earnings Results on February 26, 2020

MALVERN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2019 earnings on Wednesday, February 26 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 26, 2020. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our website for two weeks. About BioTelemetry BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care. We provide remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original

Read More »